Shares of Dynavax Technologies (DVAX) have gained 7.2% over the past four weeks to close the last trading session at 12.66,buttherecouldstillbeasolidupsideleftinthestockifshort−termpricetargetsofWallStreetanalystsareanyindication.Goingbythepricetargets,themeanestimateof24.50 indicates a potential upside of 93.5%.The mean estimate comprises four short-term price targets with a standard deviation of 6.61.Whilethelowestestimateof15 indicates an 18.5% increase from the ...